ClinicalTrials.gov
public full text
Public Domain
A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
The purpose of this study is to evaluate the yearly conditional prostate-specific antigen (PSA) progression-free survival (PFS) probabilities in high-risk localized prostate cancer (HR LPC) participants following radical prostatectomy (RP) and perioperative hormonal therapies (that is, hormonal treatment before RP and / or after RP) over 5 years.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Translational perspectives on MSMB and CRISP3 expression and regulation in prostate cancer#1015866
- Active Surveillance With or Without Apalutamide Treatment in Low Risk Prostate Cancer#1030076
- RELATIONSHIP BETWEEN RISK FACTORS AND LENGTH OF STAY OF PATIENTS AFTER OPEN PROSTATECTOMY AT RSU NEGARA IN 2023: A CROSS-SECTIONAL STUDY#1039172
- RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)#1125943
- Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer#800509
Record · ID 906197
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive